202211JAN

Senior Scientist - Computational Materials Science - Pfizer ( 4834200 )

The computational senior scientist will utilize state-of-the-art computational chemistry and crystallographic tools to calculate the solid-state properties of Pfizer molecules so that their properties and performance can be predicted.  This will enable Pfizer project teams to de-risk their programs and move rapidly to clinical studies in patients and ultimately to commercialization.  The role is highly collaborative and requires extensive work on multi-disciplinary project teams.  There is also a significant role to be played in the development of new computational methods to address gaps in current knowledge / capabilities.

 

Responsibilities

  • Apply state-of-the-art computational approaches to predict the properties and performance of crystalline and amorphous drug substance samples.
  • Use computational techniques (including matched molecular pair analysis, full interaction maps, solvation energy calculations and hydrogen bonding propensity analyses) to compare and rank new molecules against existing three-dimensional crystal structures (such as those in the Cambridge Crystallographic Database (CSD)).
  • Conduct Crystal Structure Prediction (CSP) calculations and free energy calculations for polymorph stability ranking.
  • Make recommendations for targeted crystallization experiments and/or modifications to the molecular structure to provide enhanced physical properties and stability of the material in the solid state.
  • Oversee the work of external partners conducting computational analyses, and provide tactical guidance and critical analysis of their work.
  • Solve scientific problems using contemporary solid state computational techniques.
  • Participate on multidisciplinary project teams, and collaborate with colleagues to define and recommend screening and characterization strategies according to project timelines.
  • Lead the development of new scientific approaches and knowledge within the global Material Sciences organization. This is an individual contributor role.

 

Basic Qualifications

  • Candidate s likely to have a PhD in Chemistry, Physics, Materials Science or Engineering, or a closely-related discipline;  Or a Master’s degree in these disciplines with 5-10 years of relevant experience in industry or academia. This is an individual contributor role.
  • Strong coding skills in a scientific programming language (such as C/C++, Python, Perl) with demonstrated evidence of coding expertise and data analysis.
  • Competency in UNIX/Linux and HPC environments for submission and monitoring of jobs.
click here for full details to apply

News

Funding Announcement: Digital Design and Manufacture of Amorphous Pharmaceuticals (DDMAP)
CMAC are excited to announce the new £1.2M award from EPSRC to lead the new international collaboration for Digital Design and Manufacture of Amorphous Pharmaceuticals (DDMAP).



This award brings together three world-leading research groups from the UK (CMAC, University of Strathclyde), Denmark (CPHarma, University of Copenhagen) and Belgium (CESPE, Ghent University) to deliver a step change in fundamental understanding of amorphous materials that will apply to real industrial challenges in medicines manufacturing. This unique centre will create a dynamic collaboration across Europe that will embrace open science and offer multi-disciplinary and multi-organisational research engagement. .... more

CMAC Vacancies
CMAC is #hiring! 📢

Do you want to make a difference in the world of #medicinesmanufacturing research? We have some amazing opportunities to join #CMAC, a world leading research centre at the heart of cutting edge innovation.

💊 We are always looking for diverse and inspiring talent
💊 We offer flexible and agile working across our opportunities
💊 We have roles for various skills and career stages

With over 10 vacancies available and more in the pipeline, there has never been a better time to contribute to our broad portfolio of #research, #translation and #skills in award-winning #facilities in #collaboration with global #pharma and technology providers.

.... more